Base editing cuts cholesterol in monkeys, Nature study finds
A single infusion did the work. Researchers reported in Nature that CRISPR base editors delivered by lipid nanoparticles knocked down the PCSK9 gene in the livers of cynomolgus monkeys, nearly eliminating it. Blood levels of PCSK9 fell by about 90 percent, and LDL cholesterol dropped by about 60 percent. Both effects held steady for at least eight months after the one-time treatment.
The result gives a proof of concept for using lipid nanoparticle base editors to make single-nucleotide edits to liver genes in nonhuman primates, a step toward testing this approach in patients.
Source: In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates - Nature (doi.org).
Written by the Genomes desk from the primary source linked above and checked against it. Research use only; not medical advice. Corrections: [email protected].
- FDA approves Casgevy and Lyfgenia for sickle cell disease December 8, 2023
- MHRA authorises Casgevy, world-first CRISPR gene therapy, for sickle-cell disease and beta-thalassemia November 16, 2023
- Charpentier and Doudna win 2020 Nobel Prize in Chemistry October 7, 2020
- Prime editing writes new DNA sequences without cutting both strands October 21, 2019
- Chinese scientist claims first genome-edited babies born this month November 26, 2018